inflammatory bowel disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients scheduled to undergo colonoscopy Patients 16 years and over at the time of consent acquisition Patients who voluntarily consented in writing after receiving sufficient explanation for participation in this study
Exclusion criteria
Exclusion criteria: Patients with unconfirmed diagnosis Patients with bleeding tendency Patients taking antithrombotic drugs Patients after total colectomy Patients who have difficulty collecting stool by themselves or their caregivers Patients who do not consent to this study Patients judged to be ineligible by the research director
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development of Omics-Based Japan IBD panel using bioinformatics analysis tools | — |
Secondary
| Measure | Time frame |
|---|---|
| Search for biomarkers useful for diagnosis and treatment, treatment development based on patient stratification, and search for disease onset preventive factors by using Omics-Based Japan IBD panel | — |
Countries
Japan
Contacts
Sapporo Medical University School of Medicine Department of Gastroenterology and Hepatology